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Introduction: In developing countries, tuberculosis (TB) is responsible for almost 250 000 deaths
among children yearly. Active TB in children with human immunodeficiency virus (HIV) infection is
difficult to diagnose and progresses rapidly to death. The aim of this preliminary study was to
investigate the prevalence and clinical correlates of TB-related illness among HIV-infected
children admitted to an infectious diseases ward in Peru, a country where TB is highly endemic.
Method: Forty-seven HIV-infected children admitted for a suspected infectious process in a
Peruvian hospital were investigated for evidence of clinical tuberculosis by auramine stain,
culture, and polymerase chain reaction (PCR) of clinical specimens.
Results: Eight children (17%) had evidence of tuberculosis, including five with positive cultures
and three with positive PCR tests only. Weight loss was the only feature associated with a positive
test for tuberculosis. Radiological changes were very common in both TB-positive and TB-
negative groups and these changes were not useful to identify TB-positive cases.
Conclusions: Weight loss may be used to identify high-risk HIV positive children who require more
aggressive evaluation for tuberculosis. Radiological changes were common in both TB-positive
and TB-negative groups.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.* Corresponding author. Tel.: +1 504 988 2511; fax: +1 504 988 7313.
E-mail address: oberhel@tulane.edu (R.A. Oberhelman).
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Table 1 Epidemiologic and clinical characteristics of 47
HIV-infected children hospitalized in the infectious diseases
ward of the Instituto de Salud del Nin˜o, Lima, Peru, 2000
Characteristics TB disease
Positive
n = 8 (%)
Negative
n = 39 (%)
Clinical features
Male 6 (75) 19 (49)
Age (in years)
<1 1 (13) 12 (31)
1—5 6 (75) 15 (38)
>5 1 (13) 12 (31)
BCG Scar 7 (88) 29 (74)
Previous TB disease 0 (0) 6 (15)
Contact with an
adult with TB
4 (50) 24 (62)
Household contact 4 (50) 23 (59)
Isoniazid prophylaxis 2 (25) 17 (44)
Respiratory disease 8 (100) 31 (79)
Bronchopneumonia 7 (88) 24 (62)
Bronchi-alveolar
obstruction
5 (63) 14 (36)
Respiratory distress 8 (100) 26 (67)
Signs and symptoms
Cough >14 days 7 (88) 26 (67)
Sputum production 7 (88) 31 (79)
Dyspnea 5 (63) 21 (54)
Hemoptysis 0 (0) 4 (10)
Thoracic pain 1 (13) 5 (13)
Fever 8 (100) 31 (79)
Night sweats 5 (63) 25 (64)
Weight loss 8 (100) * 21 (54) *
Weight loss for two
or more weeks
5 (63) 11 (28)
Anorexia 6 (75) 26 (67)
Weakness 7 (88) 31 (79)
Diarrhea 6 (75) 20 (51)
Abnormal Chest X rays 7 (88) 39 (100)
Nutritional status and HIV status
Height-for-age >2 SD 6 (75) 21 (54)
Weight-for-height <2 SD 4 (50) 12 (31)
Opportunistic parasites 0 (0) 3 (8)
Meets AIDS definition 6 (75) 28 (72)
Anti-retroviral treatment 0 (0) 5 (13)
Severe immunosuppression
(%CD4<15%)
6 (75) 23 (59)
Mean %CD4+ cells (SD) 9.9 (5.2) 12.3 (7.9)
TB, tuberculosis; HIV, human immunodeficiency virus; AIDS,
acquired immunodeficiency syndrome; INS, Instituto de Salud
del Nin˜o; BCG, Bacillus Calmette—Gue´rin; SD, standard deviation;
CD4: lymphocyte CD4+ count.
* p Value <0.05.children with human immunodeficiency virus (HIV) infection
is difficult to diagnose and progresses rapidly to death.1
Because positive cultures occur in less than 40% of pediatric
cases,2 presumptive diagnosis of active TB in this population
is often based on clinical criteria without microbiological
confirmation.1,2 This leads to over-diagnosis since active TB is
easily confused with other HIV-associated lung conditions.3
However, the diagnosis of active TB should be pursued in
symptomatic HIV-infected children to ensure early treatment
and improve survival.
The aim of this preliminary study was to investigate the
prevalence and clinical correlates of TB-related illness
among HIV-infected children admitted to an infectious dis-
eases ward in Peru, a country where TB is highly endemic.
For purposes of the study, TB-positive children were
defined by the presence of any positive test for TB, including
positive auramine stain, positive culture for Mycobacterium
tuberculosis (MTB), or positive results with the hemi-nested
IS6110 polymerase chain reaction assay developed by our
group.4 At least two respiratory secretion cultures, defined as
sputa, nasopharyngeal aspirates (NPA), and nasogastric aspi-
rates (NGA), were obtained from each subject. TB culture of
NPA specimens was shown to have a similar yield to NGA
specimens in a previously published pediatric study from this
site.5 While a positive PCR result is less definitive than a
positive culture and could impact case specificity, we believe
that combining PCR and culture in the case definition
provides a more accurate method of case ascertainment
than culture and/or smear alone, which have very reduced
sensitivity for the detection of MTB disease in children. While
any operational definition of pediatric TB has limitations,
especially in an HIV-infected population, we chose this
definition to identify the subgroup of HIV-infected children
most likely to have TB-related disease to compare them
with HIV-infected children admitted for other infectious
complications.
Methods
From January to December 2000, we enrolled children under
14 years of age who had documented HIV infection and were
hospitalized at the Instituto de Salud del Nin˜o in Lima, Peru,
for evaluation of any suspected infectious disease process.
HIV infection was confirmed by Western blot and HIV-1 env
DNA gene detection by PCR.6 Children on antituberculous
treatment or unable to provide specimens for TB screening
were excluded. Demographic and clinical information was
collected. Bacillus Calmette—Gue´rin (BCG) immunization
was recorded based on presence of BCG scar, and TB skin
testing (TST) with purified protein derivative was performed.
Nutritional status was assessed using Z scores, and chest X-
rays were examined by a pediatric pulmonologist. CD4+
lymphocytes were measured using the Becton Dickinson
Immunocytometry System, using %CD4+ for immunological
status determination as recommended by the Centers for
Disease Control and Prevention (no suppression: %CD4+  25,
moderate suppression: %CD4+ = 15—24, and severe suppres-
sion: %CD4+ < 15).7 At the time of the study antiretroviral
treatment was only available for a limited number of children
through non-governmental organizations, and it was not
available through this study.Children were asked to provide spontaneous sputum (Sp)
when able, otherwise nasogastric (NGA) and/or nasophar-
yngeal aspirates (NPA) were obtained. At least two speci-
mens categorized as Sp, NGA, or NPA were obtained from
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Table 2 Characteristics of eight TB-positive children at the Instituto de Salud del Nin˜o, Lima, Peru, 2000




1 2y 3m 5 C3 AC, HE Probable NPA
2 4y 4m 18 B2 AC, HE Probable NPA
3 8y 3 B3 AC Probable BAL
4 6m 13 B3 AC, HE Definite S
5 1y 3m 10 C3 AC Definite CSF CSF
6 1y 11m 9 C3 AC Definite S
7 2y 2m 15 B2 AC, A Definite NPA NPA
8 3y 7m 6 B3 Normal Definite NPA S
TB, tuberculosis; HIV, human immunodeficiency virus; AC, alveolar consolidation; N, necrosis; A, atelectasis; HE, hilar enlargement; TA,
trapped air; HL, hilar lymphadenopathy; NPA, nasopharyngeal aspirates; BAL, bronchoalveolar lavage fluid; CSF, cerebrospinal fluid; S, stool.each subject analyzed. Two stool (S) specimens were also
analyzed for each subject, and bronchoalveolar lavage (BAL)
and cerebrospinal fluid (CSF) were collected if clinically
indicated. All the specimens were screened for TB using
auramine stain, microscopic observation drug susceptibility
(MODS) culture technique, and nested IS6110 polymerase
chain reaction (PCR), following previously described tech-
niques.4,8 Children with any positive test for TB by culture or
PCR were classified as TB-positive. All laboratory results
were provided to clinicians managing the children’s medical
therapy, and individual decisions about antituberculous
therapy were made by clinicians with the aid of these
results.
Epidemiological and clinical characteristics of TB-posi-
tive and TB-negative subjects were compared using the
Fisher’s exact test and the Student’s t-test. Odds ratios
(OR) were estimated by exact logistic regression to evaluate
risk factors by using LogXact version 5.0. This method yields
exact p values and confidence intervals (CI) no matter how
small or imbalanced are the data. Quantitative variables
not following normal distribution were analyzed with non-
parametric statistics to compare distributions (Mann—Whit-
ney U-test). Categorization of the duration of any symptom
was done using the concept of suspected TB disease in a
patient with a history of two or more weeks of complaints.
ORs were adjusted by age, %CD4+, and chronic malnutrition
(weight-for-height less than two standard deviations (<2
SD) below the mean). Written consent for inclusion into the
study was obtained from the participant’s caregivers. The
Institutional Review Boards of the Johns Hopkins Bloomberg
School of Public Health, the Asociacio´n Bene´fica PRISMA,
and the Instituto de Salud del Nin˜o of Lima, Peru approved
the study.
Results
Epidemiological and clinical characteristics of the 47 children
are summarized in the TB-positive and TB-negative groups in
Table 1. In the entire study population, 53% were male, and
the mean age was 3.6 years (range 0.3—12.2 years). Eighty-
three percent of the children reported respiratory com-
plaints, 83% had fever, and 55% had diarrhea. All children
had a TST response of 0 mm. Fifty-seven percent of the
children had height-for-age >2 SD below the US NationalCenter for Health Statistics (NCHS) mean, and 34% had
weight-for-height >2 SD below the mean. Flow cytometry
data were available for 90% of the children, with a median
%CD4+ count of 11%.
Seventeen percent of the children (8/47) were TB-posi-
tive. Among the eight TB-positive children, three were posi-
tive by PCR test only, two by culture only, and three by both
culture and PCR (Table 2). None of the specimens were
auramine stain positive. Culture-positive specimens were
stool in three cases and one case each in NPA and cerebrosp-
inal fluid. No significant differences in age, gender, and
%CD4+ were found between TB-positive and TB-negative
children. For those children who reported a weight loss
the median time for TB-positive children was 2.4 weeks
(range 1—8), and for TB-negative children was 2.0 weeks
(range 1—20). Weight loss (OR = 8.86, 95% CI = 1.24, infinity,
p = 0.027) was significantly associated with TB disease.
Weight loss for two or more weeks was a marginal significant
risk factor for TB disease (OR = 5.45, 95% CI = 0.91—32.61,
p = 0.063). After controlling for age in weeks, %CD4+, and
chronic malnutrition, weight loss (adjusted OR = 13.99, 95%
CI = 1.34, infinity, p = 0.025) and weight loss for more than
two weeks (OR = 11.16, 95% CI = 1.18—105.45, p = 0.035)
remained significantly associated with TB disease. Radiolo-
gical alterations were common even in the TB-negative
group, with no significant difference in radiological patterns
between the two groups.
Discussion
Because adequate detection of MTB is difficult in young
children with pulmonary disease, establishing a diagnosis
of active TB in children remains challenging. In children,
results of smears and cultures from samples obtained by
invasive and non-invasive methods are often falsely nega-
tive.9,10 Many clinicians use a clinical case definition of TB
based on a scoring system that includes: TST, clinical signs
and symptoms consistent with TB, abnormal chest radio-
graphy, contact investigation, and therapeutic response.2
These systems frequently fail to identify active TB in HIV-
infected children, leading to inaccurate diagnosis andmaking
the diagnosis of TB highly speculative.3
In this study, even when the majority of the children had
pulmonary symptoms suggestive of pulmonary TB (PTB), only
Tuberculosis co-infection in HIV-infected children in Peru 28117% had a positive test and 10% were culture-proven, which
agrees with previous reports.11 Interestingly, three of the five
culture-positive cases were detected by stool culture, a
method which is often not attempted. Stool culture for
MTB is relatively insensitive and technically challenging,
but it has been used successfully in many developing coun-
tries12,13 and deserves consideration because the specimen is
so easily obtainable.
Because the diagnosis of active TB in this population is
uncertain, any clinical strategy that results in improved
detection of MTB will potentially improve survival by promot-
ing early use of anti-TB therapy. Any HIV-infected children
with signs suggestive of lung involvement should be screened
for TB disease, especially if there is a history of weight loss. In
this study all of the TB-positive children had lung involve-
ment, and weight loss was the only predictive clinical feature
for a positive TB test, even after removing the effect of the
immune status and age.
The diagnosis of active TB cases in this study relied on the
PCR and culture results, which are the only possible means of
detecting TB disease in our environment, in spite of their
limitations as previously described. While PCR has been used
for PTB screening in children,4,14 the clinical significance of a
positive PCR result in TB-infected patients without clinical
disease is difficult to interpret, as it may represent latent
infection or low-grade active disease.10 However, until new
effective diagnostic tools become available, HIV-infected
children with a positive PCR test should be treated as if they
have active TB, because their immunosuppression and their
high risk for developing active disease justify it.2,14 In popu-
lations such as ours, weight loss may be a useful marker to
identify HIV-infected children at increased risk for clinical
TB.
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